CASI Pharmaceuticals
CASI
#10786
Rank
NZ$7.42 M
Marketcap
NZ$0.36
Share price
0.00%
Change (1 day)
-84.05%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.82. In 2024 the company made an earnings per share (EPS) of NZ-$4.46 a decrease over its 2023 EPS that were of NZ-$3.52.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.654.32%
2024NZ-$4.4626.73%
2023NZ-$3.52-32.89%
2022NZ-$5.2411.9%
2021NZ-$4.68-38.44%
2020NZ-$7.61-8.96%
2019NZ-$8.3650%
2018NZ-$5.5777.78%
2017NZ-$3.135.88%
2016NZ-$2.96-22.73%
2015NZ-$3.83-76.09%
2014NZ-$16.02318.18%
2013NZ-$3.83-71.79%
2012NZ-$13.5865.96%
2011NZ-$8.19-50%
2010NZ-$16.37-18.97%
2009NZ-$20.20-63.64%
2008NZ-$55.563.57%
2007NZ-$53.64-60.56%
2006NZ-$136.0297.22%
2005NZ-$68.97-2.7%
2004NZ-$70.88-45.59%
2003NZ-$130.27-61.8%
2002NZ-$341.01-25.52%
2001NZ-$457.87-21.38%
2000NZ-$582.3913.86%
1999NZ-$511.51149.53%
1998NZ-$204.9998.15%
1997NZ-$103.4510.2%
1996NZ-$93.87